Skip to content

Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes

Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01377688
Acronym
DKDPilot
Enrollment
19
Registered
2011-06-21
Start date
2011-10-31
Completion date
2014-05-31
Last updated
2014-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Kidney Disease

Keywords

DKD

Brief summary

We propose to pilot a telehealth approach to evaluate components of risk communication by: 1. Providing personalized tailored patient feedback to help initiate and maintain specific diabetic kidney disease (DKD)-related behaviors (e.g., medication adherence, weight, exercise, diet, smoking cessation) to reduce their risks. 2. Evaluating how this feedback can be incorporated into clinical care by examining 6 month patient outcomes. Specific Aims are: 1. To evaluate the feasibility and acceptability of providing both patients and their provider feedback on individuals' DKD risk via the telehealth intervention and incorporating it into regular clinical practice. 2. If improvements in outcomes are found, to estimate the cost of the program in terms of the patient, provider, and overall costs of implementing the program.

Detailed description

We propose an innovative telehealth approach that has reduced antecedents of kidney disease, including poor blood pressure and glucose control, but has never been used to treat DKD. To mitigate the growing burden of DKD, these studies are designed to determine whether a potentially scalable, telehealth intervention effectively slows progression of DKD in a diverse US population and whether it is also cost-effective. The intervention simultaneously addresses medication management and behavioral therapies and education that seek to optimize adherence and self-efficacy. This proposed pilot trial will begin to evaluate if a multifactorial telehealth intervention may be effective in reducing progression of DKD.

Interventions

None listed

Sponsors

Duke University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of diabetes with progressive kidney disease

Exclusion criteria

* Metastatic cancer * Dementia * Psychosis * No Access to phone * Diagnosis of non-diabetic kidney disease

Design outcomes

Primary

MeasureTime frame
Blood pressure and /or Estimated Glomerular Filtration Rate (eGFR)6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026